Showing results (111-120 of 152) with videos related to
Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibodyAdalbert Krawczyk, Michaela A E Arndt, Ludger Grosse-Hovest, et al.Plos Pathogens|September 19, 2022
The secreted protein Cowpox Virus 14 contributes to viral virulence and immune evasion by engaging Fc-gamma-receptorsRavi F Iyer, David M Edwards, Philipp Kolb, et al.Proceedings of the National Academy of Sciences of the United States of America|February 20, 2024
Diverse cytomegalovirus US11 antagonism and MHC-A evasion strategies reveal a tit-for-tat coevolutionary arms race in hominidsCosima Zimmermann, Gabrielle M Watson, Liane Bauersfeld, et al.European Journal of Immunology|March 23, 2013
A natural tapasin isoform lacking exon 3 modifies peptide loading complex functionNele Beutler, Sebastian Hauka, Alexandra Niepel, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 29, 2020
Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samplesAnna M Eis-Hübinger, Mario Hönemann, Jürgen J Wenzel, et al.Journal of Virology|November 30, 2018
Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus CytomegalovirusPhilipp Kolb, Steven Sijmons, Matthew R McArdle, et al.The Journal of Experimental Medicine|January 12, 2005
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145Astrid Krmpotic, Milena Hasan, Andrea Loewendorf, et al.Journal of Virology|September 19, 2014
M27 expressed by cytomegalovirus counteracts effective type I interferon induction of myeloid cells but not of plasmacytoid dendritic cellsMarius Döring, Irina Lessin, Theresa Frenz, et al.Frontiers in Immunology|November 21, 2022
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?Máté Krausz, Noriko Mitsuiki, Valeria Falcone, et al.BMJ Open|November 2, 2023
Tiza-<u>T</u>itre <u>i</u>ncrease and enhanced immunity through an adjuvanted, recombinant herpes <u>z</u>oster subunit v<u>a</u>ccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort studyStephanie Vollmer-Raschdorf, Jassin Rashidi-Alavijeh, Sebastian Voigt, et al.Pageof 16